Right now, the biggest stories for healthtech founders: Regulators are tightening the rules on healthcare AI and telehealth; Interoperability is becoming the new healthcare software moat; Provider software is turning documentation into revenue lift — and 2 more. Real stories, real sources, updated every few hours. Not generated guesses.
FDAhigh engagement
Regulators are tightening the rules on healthcare AI and telehealth
A separate thread shows the regulatory surface area getting sharper: FDA warning letters to telehealth and device companies, CMS billing changes, MHRA-FDA regulatory collaboration, EU AI Act compliance timing, and liability concerns for AI misdiagnosis. Founders in regulated health tech are being forced to invest earlier in compliance, evidence, and post-market controls.
Draft a post from this →interoperabilityhigh engagement
Interoperability is becoming the new healthcare software moat
Multiple signals center on interoperability as a product and regulatory priority: ONC's interoperability proving ground, CMS interoperability and prior authorization work, HL7/FHIR production guidance, EHR integrations, identity verification for Epic, and broader provider moves off legacy systems. This is the infrastructure layer founders must solve to sell into healthcare at scale.
Draft a post from this →clinical documentationmedium engagement
Provider software is turning documentation into revenue lift
Several signals point to the operational software stack for clinicians and practices: AI clinical assistants, ambient documentation, coding automation, insurance verification, treatment-plan recapture, and secure U.S.-based documentation for ASCs. These products are all aimed at improving throughput, reducing admin burden, and capturing more revenue in provider workflows.
Draft a post from this →healthcare AIhigh engagement
Healthcare AI vendors are winning contracts and fresh capital
A wide set of healthcare AI and automation vendors are gaining traction through enterprise adoption, financing, and product validation. This includes ambient documentation, surgical coding, medical coding, physician-centric AI, care workflow orchestration, and enterprise AI governance positioned for regulated environments.
Draft a post from this →diagnosticshigh engagement
Diagnostics AI is shifting from pilots to clinical scale
Tempus and several diagnostics-adjacent companies are highlighting screening, pathology, and validation work: Tempus is getting market attention while launching an open-source digital pathology consortium and multi-center model validation, and other startups are pushing lung nodule detection, ECG screening, PCR clearance, and lab-test modernization. The common thread is evidence generation and diagnostic workflow expansion.
Draft a post from this →